{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:02:38Z","timestamp":1791068558327,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.rmed.2012.01.001","type":"journal-article","created":{"date-parts":[[2012,1,29]],"date-time":"2012-01-29T11:07:40Z","timestamp":1327835260000},"page":"581-587","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":113,"title":["Rituximab therapy for refractory interstitial lung disease related to antisynthetase syndrome"],"prefix":"10.1016","volume":"106","author":[{"given":"I.","family":"Marie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Dominique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Janvresse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Levesque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-F.","family":"Menard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2012.01.001_bib1","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/qjmed\/77.1.1019","article-title":"Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes","volume":"77","author":"Marguerie","year":"1990","journal-title":"Q J Med"},{"key":"10.1016\/j.rmed.2012.01.001_bib2","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/rheumatology\/kem045","article-title":"Anti-synthetase syndrome: a new autoantibody to phenylalanyl transfer RNA synthetase (anti-Zo) associated with polymyositis and interstitial pneumonia","volume":"46","author":"Betteridge","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rmed.2012.01.001_bib3","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1183\/09031936.00104310","article-title":"Antisynthetase syndrome positive for anti-threonyl-tRNA synthetase (anti-PL7) antibodies","volume":"37","author":"Hervier","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2012.01.001_bib4","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.4049\/jimmunol.162.4.2315","article-title":"Anti-KS: identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease","volume":"162","author":"Hirakata","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.rmed.2012.01.001_bib5","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1378\/chest.10-0180","article-title":"Interstitial lung disease associated with the idiopathic inflammatory myopathies. What progress has been made in the past 35 years?","volume":"138","author":"Connors","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2012.01.001_bib6","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1002\/art.30513","article-title":"Short term and long term outcome of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients","volume":"63","author":"Marie","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rmed.2012.01.001_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2011.06.007","article-title":"Therapy of polymyositis and dermatomyositis","author":"Marie","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.rmed.2012.01.001_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2011.05.017","article-title":"No hepatitis B reactivation in a patient with refractory antisynthetase syndrome successfully treated with rituximab","author":"Andres","year":"2011","journal-title":"Jt Bone Spine"},{"key":"10.1016\/j.rmed.2012.01.001_bib9","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/ard.2005.045898","article-title":"Rituximab in the treatment of antisynthetase syndrome","volume":"65","author":"Brulhart","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rmed.2012.01.001_bib10","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/01.rhu.0000182155.08982.60","article-title":"Rituximab in the treatment of refractory dermatomyositis","volume":"11","author":"Chiappetta","year":"2005","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.rmed.2012.01.001_bib11","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1001\/archderm.143.6.763","article-title":"A pilot trial of rituximab in the treatment of patients with dermatomyositis","volume":"143","author":"Chung","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.rmed.2012.01.001_bib12","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jaad.2006.05.068","article-title":"Rituximab for the treatment of the skin manifestations of dermatomyositis: a report of 3 cases","volume":"56","author":"Dinh","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.rmed.2012.01.001_bib13","first-page":"1230","article-title":"Longlasting remissions after treatment with rituximab for autoimmune myositis","volume":"35","author":"Feist","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rmed.2012.01.001_bib14","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1093\/rheumatology\/kep147","article-title":"Efficacy of rituximab in refractory and relapsing myositis with anti-JO1 antibodies: a report of two cases","volume":"48","author":"Frikha","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rmed.2012.01.001_bib15","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1136\/ard.2004.029694","article-title":"Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases","volume":"64","author":"Gottenberg","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rmed.2012.01.001_bib16","doi-asserted-by":"crossref","first-page":"306","DOI":"10.4103\/0028-3886.79163","article-title":"Resistant dermatomyositis complicated by tubercular myositis and successfully treated with rituximab","volume":"59","author":"Jois","year":"2011","journal-title":"Neurol India"},{"key":"10.1016\/j.rmed.2012.01.001_bib17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/RHU.0b013e31821072b7","article-title":"Successful use of rituximab in recalcitrant skin predominant dermatomyositis","volume":"17","author":"Joshi","year":"2011","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.rmed.2012.01.001_bib18","first-page":"1369","article-title":"Efficacy of rituximab in refractory polymyositis","volume":"32","author":"Lambotte","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rmed.2012.01.001_bib19","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/art.20849","article-title":"Rituximab in the treatment of dermatomyositis: an open-label pilot study","volume":"52","author":"Levine","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rmed.2012.01.001_bib20","series-title":"Rituximab treatment in patients with refractory inflammatory myopathies","author":"Mahler","year":"2011"},{"key":"10.1016\/j.rmed.2012.01.001_bib21","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/RHU.0b013e3181bb8e70","article-title":"Treatment of adult inflammatory myositis with rituximab: an emerging therapy for refractory patients","volume":"15","author":"Majmudar","year":"2009","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.rmed.2012.01.001_bib22","first-page":"1864","article-title":"Rituximab for refractory polymyositis: an open-label prospective study","volume":"34","author":"Mok","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rmed.2012.01.001_bib23","first-page":"1021","article-title":"Rituximab as therapy for refractory polymyositis and dermatomyositis","volume":"33","author":"Noss","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rmed.2012.01.001_bib24","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s00296-009-1000-x","article-title":"Long-term remission of severe refractory dermatopolymyositis with a weekly-scheme of immunoglobulin followed by rituximab therapy","volume":"30","author":"S\u00e1nchez-Ram\u00f3n","year":"2010","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.rmed.2012.01.001_bib25","first-page":"887","article-title":"Clinical outcome following B cell depletion therapy in eight patients with refractory idiopathic inflammatory myopathy","volume":"26","author":"Sultan","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rmed.2012.01.001_bib26","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jbspin.2007.05.011","article-title":"Successful treatment of cardiac involvement in dermatomyositis with rituximab","volume":"75","author":"Touma","year":"2008","journal-title":"Jt Bone Spine"},{"key":"10.1016\/j.rmed.2012.01.001_bib27","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/rheumatology\/kep157","article-title":"Rituximab treatment of the anti-synthetase syndrome: a retrospective case series","volume":"48","author":"Sem","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rmed.2012.01.001_bib28","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmed.2012.01.001_bib29","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"issue":"Suppl. 5","key":"10.1016\/j.rmed.2012.01.001_bib30","first-page":"1","article-title":"Clinical respiratory physiology: standardized lung function testing: working party report: standardization of lung function tests","volume":"19","author":"Quanjer","year":"1983","journal-title":"Bull Eur Physiopathol Respir"},{"key":"10.1016\/j.rmed.2012.01.001_bib31","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0720-048X(03)00094-9","article-title":"Serial chest CT findings in interstitial lung disease associated with polymyositis-dermatomyositis","volume":"49","author":"Bonnefoy","year":"2004","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.rmed.2012.01.001_bib32","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1183\/09031936.03.00026703","article-title":"Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis and polymyositis","volume":"22","author":"Cottin","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2012.01.001_bib33","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/thorax.58.2.143","article-title":"Radiological versus histological diagnosis in UIP and NSIP: survival implications","volume":"58","author":"Flaherty","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2012.01.001_bib34","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/j.1440-1843.2009.01626.x","article-title":"Diagnosing fibrotic lung disease: when is high-resolution computed tomography sufficient to make a diagnosis of idiopathic pulmonary fibrosis?","volume":"14","author":"Schmidt","year":"2009","journal-title":"Respirology"},{"key":"10.1016\/j.rmed.2012.01.001_bib35","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1148\/radiol.2483071378","article-title":"Prognostic determinants among clinical, thin-section CT, and histopathologic findings for fibrotic idiopathic interstitial pneumonias: tertiary hospital study","volume":"249","author":"Shin","year":"2008","journal-title":"Radiology"},{"key":"10.1016\/j.rmed.2012.01.001_bib36","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1164\/ajrccm.161.2.ats3-00","article-title":"Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European respiratory Society (ERS)","volume":"161","author":"American Thoracic Society","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2012.01.001_bib37","series-title":"Rituximab restored the muscle power and rescued from a refractory fatal respiratory failure in a patient with elderly-onset polymyositis","author":"Gheita","year":"2011"},{"key":"10.1016\/j.rmed.2012.01.001_bib38","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s10067-010-1399-1","article-title":"Spontaneous pneumomediastinum secondary to refractory dermatomyositis successfully treated with rituximab","volume":"29","author":"Lee","year":"2010","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.rmed.2012.01.001_bib39","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1007\/s00296-009-0859-x","article-title":"Rituximab in life threatening antisynthetase syndrome","volume":"29","author":"Vandenbroucke","year":"2009","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.rmed.2012.01.001_bib40","first-page":"88","article-title":"Refractory dermatomyositis associated with chronic organizing pneumonia treated with rituximab: report of one case","volume":"137","author":"Y\u00e1\u00f1ez","year":"2009","journal-title":"Rev Med Chil"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611112000297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611112000297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:16:52Z","timestamp":1760613412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611112000297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0954611112000297"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2012.01.001","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rituximab therapy for refractory interstitial lung disease related to antisynthetase syndrome","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2012.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}